Exact Sciences Corp. (Nasdaq: EXAS) narrowed first quarter losses more than expected as revenue surged. Shares of the molecular diagnostics company leaped $6.34 to close at $30.14.
Exact Sciences narrows losses
April 27, 2017 at 16:49 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.